- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Gamma wave.
Displaying page 1 of 1.
| EudraCT Number: 2016-004433-24 | Sponsor Protocol Number: 59498 | Start Date*: 2017-05-17 |
| Sponsor Name:Leids Universitair Medisch Centrum | ||
| Full Title: ACE inhibition in Fontan patients: its effect on body fluid regulation. | ||
| Medical condition: Patients with univentricular hearts palliated by the Fontan procedure | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-000940-28 | Sponsor Protocol Number: Final Protocol version 6 | Start Date*: 2007-11-28 | ||||||||||||||||
| Sponsor Name:University Hospitals of Leicester NHS Trust | ||||||||||||||||||
| Full Title: The Rimonabant in treatment of Prediabetes Study: a randomised clinical trial of Rimonabant in the treatment of patients with Prediabetes | ||||||||||||||||||
| Medical condition: Impaired Glucose tolerance and Impaired fasting Glycaemia (Together known as Prediabetes) | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2013-001496-21 | Sponsor Protocol Number: LOC-2013 | Start Date*: 2013-06-18 |
| Sponsor Name:Harry Scheinin | ||
| Full Title: The Neural Mechanisms of Anesthesia and Human Consciousness | ||
| Medical condition: No medical condition or disease involved. The study subjects are healthy volunteers. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: FI (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2022-002400-20 | Sponsor Protocol Number: 81866 | Start Date*: 2023-02-28 | |||||||||||
| Sponsor Name:Amsterdam UMC, location VUmc | |||||||||||||
| Full Title: Feasibility of empagliflozin as treatment for idiopathic pulmonary arterial hypertension | |||||||||||||
| Medical condition: Idiopathic Pulmonary Arterial Hypertension | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.